Search Results

Drug Development

Regenera Pharma Enrolls First Patient in US Phase 3 Study of RPh201 in NAION, Advances Phase 2 Study in Alzheimer’s Disease in Canada

RPh201 development in US supported by Fast Track Designation by US Food and Drug Administration

August 2, 2018

·

4 min read

Regenera Lists On ASX

October 19, 2005

·

2 min read

Business

Regenera Signs MOU With Leading Eye Research Center In South Asia For Clinical Trials Of Visagen

October 19, 2005

·

2 min read

Press Releases

Surrozen to Present at Upcoming Healthcare Investor Conferences

November 7, 2024

·

4 min read

Press Releases

Regeneration Biomedical Presents Data on First Cohort from an Ongoing Phase I Clinical Trial of Stem Cell Therapy Delivered Directly into the Brains of Patients with Alzheimer’s Disease

October 29, 2024

·

4 min read

Press Releases

Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children’s Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia

October 28, 2024

·

5 min read

Deals

Advanced Ocular Systems, Inc. Announces Proposed Merger With Regenera Limited; New Global Ophthalmic Company Offers Strong Pipeline Of Refractive And Retinal Technology And Products

October 31, 2005

·

1 min read

Press Releases

Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors

August 28, 2024

·

4 min read

Press Releases

Regeneration Biomedical to Present Data on First Two Subjects in a Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brains of Patients with Alzheimer’s Disease

July 29, 2024

·

3 min read

Business

Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights

Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported first quarter 2024 financial results.

May 13, 2024

·

6 min read